TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ANIK

Anika Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

20.40$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANIK
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.62 2.55 1.57 2.71 2.38 2.57 0.92 0.57 0.30 -0.12 0.37 0.78
0.31 0.25 0.25 0.28 0.40 0.42 1.05 0.98 0.99 0.97 0.55 0.40
0.11 0.15 0.22 0.39 0.75 0.42 0.38 0.76 0.98 1.04 0.89 0.70
-0.45 0.10 0.22 0.47 0.92 0.65 1.72 -0.24 1.01 – – –
0.25 0.19 -1.05 -0.16 -0.22 -0.46 -0.95 -1.01 -0.81 -0.83 -0.89 -0.06
0.10 0.60 0.93 0.60 0.32 0.20 0.11 0.35 0.51 0.37 0.53 0.48
-0.54 -1.97 -0.45 -0.83 -3.42 2.76 -5.01 -0.21 -0.51 -0.37 -0.57 -0.03
0.00 0.00 0.00 0.00 – – 0.09 0.04 0.02 – – –
-0.42 0.07 -1.65 0.02 -2.04 -2.09 -0.02 -0.03 -0.06 -0.34 -0.74 -0.66
– – – -0.04 -0.04 -0.04 -0.02 -0.01 -0.02 0.00 0.00 –
0.35 0.13 -1.54 0.02 -1.97 -0.57 -0.27 -0.46 -0.33 -0.43 -0.86 -0.74
2.41 0.69 -0.43 1.92 -3.01 4.76 -4.33 -0.10 -0.55 -0.92 -1.07 0.02
2.52 1.95 0.65 2.11 2.06 2.38 0.80 0.22 -0.21 -0.49 -0.16 0.30

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?